LNSR logo

LENSAR INC

LNSRNASDAQ
🏆 #4130 by market capEarnings Nov 12US Equity
$5.92▲ $0.00 (+0.00%)
Latest quote
🔔
Track LNSR
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.0%
7d▼ 2.8%
14d▼ 2.3%
30d▼ 14.8%
ytd▼ 49.0%
1y▼ 50.3%
🏦Market Cap
$73M
Small Cap
📈Revenue Growth (YoY)
9.2%
Slowing
📊Gross Margin
48.0%
Healthy
💵FCF Margin
-12.2%
Thin
⚖️P/S Ratio
1.2x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$5.88 – $5.92
52-Week Range
$4.95 – $12.94
Volume (shares)
411
Avg Volume (shares)
—
Shares Outstanding
12.3M
Next Earnings
2026-11-12

Fundamentals Snapshot

Annual Revenue
$58M
Last Q Revenue
$16M
P/E Ratio
4.6
P/S Ratio
1.2x
EPS (TTM)
$2.82
Dividend Yield
0.00%
Dilution (1yr)
+3.8%
LNSR logo

LENSAR INC

LNSR
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$58M▲ +9.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
46.4%▼ −4.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$25M▲ +130.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$15M▲ +513.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
12.1M▲ +3.8% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$10M▼ −$3M YoY
StockOtter · stockotter.space

About LENSAR INC

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.